Microalbuminuria (Moderate Albumin Excretion) and its relationship with Silent myocardial ischemia in treatment naïve type II diabetic patients.

Diabetes mellitus Microalbuminemia Moderate Albumin excretion Myocardial Infarction Silent myocardial ischemia

Journal

Pakistan journal of medical sciences
ISSN: 1682-024X
Titre abrégé: Pak J Med Sci
Pays: Pakistan
ID NLM: 100913117

Informations de publication

Date de publication:
Historique:
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 16 4 2020
Statut: ppublish

Résumé

To determine the frequency of microalbuminuria (MAU) or Moderate Albumin Excretion (MAE) in treatment naïve type II diabetic patients and to compare the frequency of silent myocardial ischemia in treatment naive Type-II diabetic patients with and without microalbuminuria. It was a cross sectional survey conducted in the outpatient Department, Jinnah Hospital Lahore, from 30th May 2015 to 29th November 2015. There were 227 patients, (consecutive treatment naïve type II diabetic patients), presenting to outpatient department were enrolled in the study. MAU/MAE, silent myocardial ischemia and effect modifiers like HbA1C > 7%, smoking pack years and dyslipidemia was determined. MAU/MAE was determined by urinary albumin excretion rate of 30-300 mg/24 hours and included patients underwent exercise tolerance test to diagnose silent myocardial ischemia. Out of total 165 patients (72.7%) were male and remaining 62 patients (27.3%) were female. The 54 patients (23.8%) had MAU/MAE. The 44 patients (19.4%) had silent myocardial infarction. When we cross tabulated microalbuminuria with silent myocardial infarction, result were significant. Out of 54 patients with MAU/MAE, 16 cases had silent myocardial infarction. The frequency of microalbuminuria/ Moderate Albumin Excretion in treatment naïve type II diabetic patients was high and associated with the frequency of silent myocardial ischemia in treatment naïve type II diabetic patients with and without MAU MAU/MAE.

Identifiants

pubmed: 32292459
doi: 10.12669/pjms.36.3.938
pii: PJMS-39-496
pmc: PMC7150412
doi:

Types de publication

Journal Article

Langues

eng

Pagination

496-500

Informations de copyright

Copyright: © Pakistan Journal of Medical Sciences.

Déclaration de conflit d'intérêts

Conflict of interest: None.

Références

J Am Coll Cardiol. 2012 Sep 11;60(11):960-8
pubmed: 22921971
Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1199-206
pubmed: 22526959
J Am Heart Assoc. 2017 Jul 17;6(7):
pubmed: 28716801
Circ Cardiovasc Imaging. 2013 May 1;6(3):466-77
pubmed: 23547172
Arch Intern Med. 2011 Mar 14;171(5):412-20
pubmed: 21403038
J Pak Med Assoc. 1987 Jul;37(7):165-7
pubmed: 3118070
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):141
pubmed: 23124438
Diabet Med. 2005 Jul;22(7):931-6
pubmed: 15975110
Acta Diabetol. 2013 Jun;50(3):333-40
pubmed: 22684266
J Clin Lab Anal. 2017 May;31(3):
pubmed: 27696561
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):548-57
pubmed: 23314258
Am J Cardiol. 2013 Jul 1;112(1):14-20
pubmed: 23578350
Cardiol Res. 2017 Oct;8(5):206-213
pubmed: 29118882

Auteurs

Qurban Hussain (Q)

Dr. Qurban Hussain, MBBS, FCPS Medicine. Senior Registrar Medicine, Jinnah Hospital, Lahore, Pakistan.

Mulazim Hussain Bukhari (MH)

Prof. Mulazim Hussain Bukhari, MBBS, DCP, MPhil, FCPS, PhD. Professor of Pathology and Head of Pathology UCMD, University of Lahore, Pakistan.

Faiza Afzaal (F)

Dr. Faiza Afzaal, MBBS, MCPS Anesthesia. Post Graduate Trainee FCPS Anesthesia, Jinnah Hospital, Lahore, Pakistan.

Wajiha Fatima (W)

Dr. Wajiha Fatima, MBBS, FCPS Medicine. Senior Registrar Medicine, Jinnah Hospital, Lahore, Pakistan.

Classifications MeSH